Liranaftate

This classification denotes an antifungal agent with the molecular formula C18H20N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5253IGO5X3, chemically known as o-(5,6,7,8,-tetrahydro-2-naphthyl) 6-methoxy-n-methylthio-2-pyridinecarbamate but generally known as liranaftate, which bears US NIH Compound Identifier 3936. European Medicines Agency schedules Liranaftate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08528MIG. The term LIRANAFTATE is an International Non-Proprietary Name. LIRANAFTATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule liranaftate under HS 29333999 and SITC 51574. As of Q4 2014, LIRANAFTATE remains the US FDA Preferred Term for this commodity. Liranaftate bears US NLM identifiers UMLS ID C1173390 and NCI Concept Code C66019. SMILES: S=C(OC1CC2CCCCC2CC1)N(C1NC(OC)CCC1)C.